MH 200
Alternative Names: ANPEC; MH-200; Morphine hydrochlorideLatest Information Update: 05 Apr 2022
At a glance
- Originator Daiichi Sankyo Company; Dainippon Sumitomo Pharma; Shionogi; Takeda; Tanabe Seiyaku
- Developer Daiichi Sankyo Company; Mitsubishi Tanabe Pharma Corporation; Shionogi; Sumitomo Pharma; Takeda
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer pain